H Yagi - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

H Yagi

Showing results (191-200 of 461) with videos related to

Pageof 47

Sort By:

Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|February 1, 1993

[Preoperative embolization using absolute ethanol for renal cell carcinoma--including the questionnaire survey in Japan]T Kurozumi, H Yagi, Y Koikawa, et al.

Pediatric Research|November 1, 1989

Developmental changes in agonist-mediated gastric smooth muscle contraction in the rabbitT Tomomasa, H Yagi, S Kimura, et al.

Proceedings of the National Academy of Sciences of the United States of America|April 1, 1989

Mutagenic specificity of a potent carcinogen, benzo[c]phenanthrene (4R,3S)-dihydrodiol (2S,1R)-epoxide, which reacts with adenine and guanine in DNAC A Bigger, J Strandberg, H Yagi, et al.

Cancer Immunology, Immunotherapy : CII|January 1, 1986

Augmentation of the therapeutic efficacy of adoptive tumor immunotherapy by in vivo administration of slowly released recombinant interleukin 2T Nishimura, Y Togashi, M Goto, et al.

Cancer Research|March 15, 1993

Sequence specificity in the interaction of the four stereoisomeric benzo[c]phenanthrene dihydrodiol epoxides with the supF geneH Ross, C A Bigger, H Yagi, et al.

Proceedings of the National Academy of Sciences of the United States of America|November 1, 1976

(+/-)-trans-7,8-dihydroxy-7,8-dihydrobenzo (a)pyrene: a potent skin carcinogen when applied topically to miceW Levin, A W Wood, H Yagi, et al.

Optics Letters|June 24, 2004

Diode-end-pumped 4.2-W continuous-wave Yb:Y2O3 ceramic laserJ Kong, D Y Tang, J Lu, et al.

Chemical Research in Toxicology|September 20, 2000

Marked differences in base selectivity between DNA and the free nucleotides upon adduct formation from Bay- and Fjord-region diol epoxidesS R Vepachedu, N Ya, H Yagi, et al.

Carcinogenesis|October 1, 1996

Benzo[c]phenanthrene is activated to DNA-binding diol epoxides in the human mammary carcinoma cell line MCF-7 but only limited activation occurs in mouse skinH J Einolf, S Amin, H Yagi, et al.

The Journal of Clinical Endocrinology and Metabolism|February 1, 1993

A new point mutation in the deoxyribonucleic acid-binding domain of the vitamin D receptor in a kindred with hereditary 1,25-dihydroxyvitamin D-resistant ricketsH Yagi, K Ozono, H Miyake, et al.

Pageof 47

Search research articles

Showing results (191-200 of 461) with videos related to

Sort By:

Pageof 47

Nihon Hinyokika Gakkai Zasshi. the Japanese Journal of Urology|February 1, 1993

[Preoperative embolization using absolute ethanol for renal cell carcinoma--including the questionnaire survey in Japan]T Kurozumi, H Yagi, Y Koikawa, et al.

Pediatric Research|November 1, 1989

Developmental changes in agonist-mediated gastric smooth muscle contraction in the rabbitT Tomomasa, H Yagi, S Kimura, et al.

Proceedings of the National Academy of Sciences of the United States of America|April 1, 1989

Mutagenic specificity of a potent carcinogen, benzo[c]phenanthrene (4R,3S)-dihydrodiol (2S,1R)-epoxide, which reacts with adenine and guanine in DNAC A Bigger, J Strandberg, H Yagi, et al.

Cancer Immunology, Immunotherapy : CII|January 1, 1986

Augmentation of the therapeutic efficacy of adoptive tumor immunotherapy by in vivo administration of slowly released recombinant interleukin 2T Nishimura, Y Togashi, M Goto, et al.

Cancer Research|March 15, 1993

Sequence specificity in the interaction of the four stereoisomeric benzo[c]phenanthrene dihydrodiol epoxides with the supF geneH Ross, C A Bigger, H Yagi, et al.

Proceedings of the National Academy of Sciences of the United States of America|November 1, 1976

(+/-)-trans-7,8-dihydroxy-7,8-dihydrobenzo (a)pyrene: a potent skin carcinogen when applied topically to miceW Levin, A W Wood, H Yagi, et al.

Optics Letters|June 24, 2004

Diode-end-pumped 4.2-W continuous-wave Yb:Y2O3 ceramic laserJ Kong, D Y Tang, J Lu, et al.

Chemical Research in Toxicology|September 20, 2000

Marked differences in base selectivity between DNA and the free nucleotides upon adduct formation from Bay- and Fjord-region diol epoxidesS R Vepachedu, N Ya, H Yagi, et al.

Carcinogenesis|October 1, 1996

Benzo[c]phenanthrene is activated to DNA-binding diol epoxides in the human mammary carcinoma cell line MCF-7 but only limited activation occurs in mouse skinH J Einolf, S Amin, H Yagi, et al.

The Journal of Clinical Endocrinology and Metabolism|February 1, 1993

A new point mutation in the deoxyribonucleic acid-binding domain of the vitamin D receptor in a kindred with hereditary 1,25-dihydroxyvitamin D-resistant ricketsH Yagi, K Ozono, H Miyake, et al.

Pageof 47